The medical group reported $0.63 non-GAAP EPS and $488M revenue, exceeding analyst expectations by $0.04 and $10M respectively.
Pediatrix Medical Group posted second-quarter non-GAAP earnings per share of $0.63, surpassing estimates by $0.04. Revenue reached $488M, up 4.1% year-over-year and $10M above consensus.
Net income for the quarter totaled $40 million, while adjusted EBITDA came in at $76 million. The company reaffirmed its 2026 outlook, projecting adjusted EBITDA between $280 million and $300 million.
Shares showed muted reaction in after-hours trading as investors digested the results.